WDNA vs. IBB
WDNA (WisdomTree BioRevolution Fund) and IBB (iShares Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - WDNA tracks the WisdomTree BioRevolution Index while IBB tracks the NASDAQ Biotechnology Index. Both are passively managed. Over the past 5 years, WDNA returned -5.33%/yr vs 2.10%/yr for IBB. Their correlation of 0.89 suggests significant overlap in exposure. WDNA charges 0.45%/yr vs 0.47%/yr for IBB.
Performance
WDNA vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 5.85% return, which is significantly higher than IBB's -0.68% return.
WDNA
- 1D
- 1.24%
- 1M
- -0.73%
- YTD
- 5.85%
- 6M
- 8.14%
- 1Y
- 45.86%
- 3Y*
- 2.45%
- 5Y*
- -5.33%
- 10Y*
- —
IBB
- 1D
- 1.97%
- 1M
- -1.56%
- YTD
- -0.68%
- 6M
- -2.57%
- 1Y
- 34.50%
- 3Y*
- 9.40%
- 5Y*
- 2.10%
- 10Y*
- 6.23%
WDNA vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 5.85% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
IBB iShares Nasdaq Biotechnology ETF | -0.68% | 27.98% | -2.41% | 3.76% | -13.69% | 1.27% |
Correlation
The correlation between WDNA and IBB is 0.83, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.83 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.86 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.89 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2021 | 0.89 |
The correlation between WDNA and IBB has been stable across timeframes, ranging from 0.83 to 0.89 - a consistent structural relationship.
WDNA vs. IBB - Sectors Allocation Comparison
Sectors
WDNA
IBB
Healthcare
Basic Materials
-
Consumer Defensive
-
Energy
-
Communication Services
-
-
Consumer Cyclical
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
WDNA
IBB
Basic Materials
WDNA
IBB
-
Consumer Defensive
WDNA
IBB
-
Energy
WDNA
IBB
-
Communication Services
WDNA
-
IBB
-
Consumer Cyclical
WDNA
-
IBB
-
Financial Services
WDNA
-
IBB
-
Industrials
WDNA
-
IBB
-
Real Estate
WDNA
-
IBB
-
Technology
WDNA
-
IBB
-
Utilities
WDNA
-
IBB
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. IBB — Risk / Return Rank
WDNA
IBB
WDNA vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WDNA | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | +0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.30 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 3.94 | 3.60 | +0.34 |
| Martin ratioReturn relative to average drawdown | 8.95 | 11.43 | -2.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WDNA | IBB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.81 | 1.74 | +0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | 0.10 | -0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.27 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.21 | 0.26 | -0.47 |
Drawdowns
WDNA vs. IBB - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for WDNA and IBB.
Loading charts...
Drawdown Indicators
| WDNA | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -62.85% | +3.98% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -9.63% | -2.07% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -24.85% | -13.40% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -39.82% | -19.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -31.86% | -5.64% | -26.22% |
Average DrawdownAverage peak-to-trough decline | -35.65% | -21.18% | -14.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 3.03% | +2.11% |
Volatility
WDNA vs. IBB - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 6.75% and 6.86%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.75% | 6.86% | -0.11% |
Volatility (6M)Calculated over the trailing 6-month period | 16.39% | 15.38% | +1.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.53% | 19.89% | +5.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.04% | 21.99% | +3.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.04% | 23.22% | +1.82% |
WDNA vs. IBB - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than IBB's 0.47% expense ratio.
Dividends
WDNA vs. IBB - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.31%, more than IBB's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
WDNA WisdomTree BioRevolution Fund | 4.31% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and IBB have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBB has higher volatility (6.86%) compared to WDNA (6.75%). In terms of maximum drawdown, WDNA dropped -58.87% vs IBB's -62.85%.
On 5-year performance, IBB leads with 2.10% vs -5.33% for WDNA. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 6.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IBB has performed better with a 2.10% return vs -5.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
WDNA is cheaper with a 0.45% expense ratio, compared with 0.47% for IBB.
WDNA has the higher dividend yield at 4.31%, compared with 0.23% for IBB.
WDNA tracks WisdomTree BioRevolution Index, while IBB tracks NASDAQ Biotechnology Index. They also come from different issuers: WisdomTree and iShares. Their fees differ too: 0.45% for WDNA and 0.47% for IBB.
WDNA currently has the higher Sharpe Ratio (1.81 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer